Atrial Failure
Definition
Atrial failure is the end-stage manifestation of atrial cardiomyopathy (AtCM), characterized by progressive structural, electrophysiological, and functional changes of the atria leading to clinically evident consequences. It is confirmed by the combination of AtCM markers plus either: (sources/atrial-cmp-esc-2025, rating: high)
- Persistent atrial arrhythmia (typically persistent AF, P-wave score 4), OR
- Documented heart failure (dyspnoea, fatigue, impaired quality of life attributable at least in part to atrial disease)
Atrial failure is thus the convergence of AtCM with its two principal clinical consequences: AF and HF.
Key Concepts
Pathophysiology
Atrial failure develops through progressive accumulation of: (sources/atrial-cmp-esc-2025, rating: high)
- Structural changes: Atrial enlargement, atrial fibrosis (reactive and replacement types), fibro-fatty infiltration
- Electrophysiological changes: Shortened AERP, conduction slowing, IAB progression to persistent AF
- Functional changes: Loss of reservoir, conduit, and booster pump function; impaired LA strain
Secondary functional mitral regurgitation (from LA annular dilatation) and secondary tricuspid regurgitation may indicate progressed atrial failure.
Relationship to AtCM Staging
The AtCM P-wave score provides a graded progression to atrial failure: (sources/atrial-cmp-esc-2025, rating: high)
| P-wave Score | Clinical Stage | Management |
|---|---|---|
| 0 | No AtCM | Primary prevention of risk factors |
| 1–2 | At risk for AtCM | Aggressive comorbidity management |
| 3 | Established AtCM (paroxysmal AF) | Evaluate thromboembolic risk; anticoagulation/antiarrhythmic strategies per guidelines |
| 4 + HF/structural markers | Atrial failure | Treat AF and HF per respective ESC guidelines |
Clinical Manifestations
- Persistent AF (P-wave score 4 — ECG no longer useful for P-wave analysis; AF burden/ventricular response monitoring become primary monitoring tools)
- Heart failure (dyspnoea, fatigue, reduced exercise tolerance, impaired quality of life)
- Elevated thromboembolic and cardiovascular risk
- Secondary valvular regurgitation from atrial dilatation (atrial-type secondary MR and TR)
Management
- Treat each condition (AF, HF) per respective ESC clinical guidelines (sources/atrial-cmp-esc-2025, rating: high)
- Monitoring by cardiologist with HF or AF expertise recommended, depending on local infrastructure
- Aggressive comorbidity management for remaining modifiable risk factors
- AF ablation in advanced atrial failure: appropriate strategy not yet established; ability to modify substrate and progression requires specific investigation
Prevention
Prevention of atrial failure from AtCM is the primary therapeutic goal: (sources/atrial-cmp-esc-2025, rating: high)
- Earlier identification (P-wave score 1–2) + risk factor management may slow remodelling and delay or prevent progression to atrial failure
- No dedicated RCTs exist yet in AtCM to demonstrate that earlier intervention prevents atrial failure
- Pending trial evidence: aggressive management of hypertension, obesity, diabetes, exercise capacity, and alcohol restriction (based on Class I evidence in clinical AF for reducing arrhythmia recurrence)
Contradictions / Open Questions
- Clinical definition is composite: Atrial failure requires both AtCM markers and either AF or HF — the directionality is unclear in individual patients (does AF cause HF, or does underlying AtCM cause both?). (sources/atrial-cmp-esc-2025, rating: high)
- Ablation in atrial failure: Whether catheter ablation can modify the substrate and reverse atrial failure or merely treat symptoms requires prospective RCT evidence
- Distinction from HFpEF phenotype: Interaction and ability to distinguish AtCM-related atrial failure from HFpEF phenotypes requires dedicated study; significant clinical overlap exists
Connections
- Related to concepts/Atrial-Cardiomyopathy — atrial failure is end-stage AtCM
- Related to entities/Atrial-Fibrillation — persistent AF defines advanced atrial failure
- Related to entities/Heart-Failure — HF is the other defining consequence of atrial failure
- Related to concepts/HFpEF — overlap between HFpEF and atrial failure phenotypes
- Related to concepts/Secondary-Mitral-Regurgitation — atrial-type SMR as consequence of atrial dilatation
- Related to concepts/Tricuspid-Regurgitation — secondary TR in atrial failure
- Related to sources/atrial-cmp-esc-2025